Seisa Medical Inc.

Based in the US, Seisa Medical Inc. specializes in manufacturing Class II and Class III medical devices, providing essential solutions for healthcare through implantable stents and orthopedic products. Seisa Medical Inc. operates in the medical device manufacturing sector, focusing on innovative healthcare solutions.

Founded in 1983 in El Paso, US, the company has made two notable deals, the most recent occurring on November 9, 2023. The organization was founded by Julio Chiu, who has a history of entrepreneurship; the current CEO is Eric Wong, alongside other key figures such as Kristi Arndt, Waldo Diaz, and Williams Benedicto. Seisa Medical specializes in the manufacturing of Class II and Class III medical devices and specialty components, focusing on implantable stents, tubing sets, as well as products for pediatric and orthopedic care. The company operates as a full-service contract manufacturer, providing comprehensive support through various stages of the product life cycle, including design, component manufacturing, final assembly, and packaging.

These offerings are designed to address critical healthcare needs, enhancing the quality of patient care and safety. Seisa's client base includes large medical device companies and healthcare providers, with end users ranging from hospitals to outpatient surgical centers. Their products are distributed across multiple geographical markets, including North America, Europe, and select regions in Asia, allowing them to serve a diverse array of healthcare professionals and institutions. Seisa Medical's revenue structure is primarily based on B2B transactions, where they contract with medical device companies to provide tailored manufacturing solutions.

The company engages in partnerships with its clients, offering personalized services that align with their specific needs, from prototype development to large-scale production. Transactions generally involve agreements for the supply of custom medical devices and components, with terms defined based on project scope and volume requirements. Flagship products include their advanced stent systems and specialized orthopedic devices, which are integral to their clients' portfolios. Through these arrangements, Seisa Medical establishes long-term relationships within the healthcare sector, ensuring compliance with regulatory standards while delivering high-quality medical solutions.

In November 2023, Seisa Medical Inc. was agreed to be acquired by Tekni-Plex, Inc. , a move that will enable the latter to expand into contract development and manufacturing in medical materials science. The rationale behind this acquisition is to enhance offerings for engineered materials, components, and sterile barrier products.

There are plans for the introduction of new medical devices and expansion into additional global markets, although specific details regarding product launches and targeted regions have not been disclosed.